Literature DB >> 14228536

PARALLEL ASSAYS OF THYROTROPHIN, LONG-ACTING THYROID STIMULATOR AND EXOPHTHALMOS-PRODUCING SUBSTANCE IN ENDOCRINE EXOPHTHALMOS AND PRETIBIAL MYXEDEMA.

B L PIMSTONE, R HOFFENBERG, E BLACK.   

Abstract

Keywords:  ADRENAL CORTEX HORMONES; BIOLOGICAL ASSAY; BLOOD; DRUG THERAPY; EXOPHTHALMOS; EXPERIMENTAL LAB STUDY; HYPERTHYROIDISM; LEG DERMATOSES; MYXEDEMA; PHARMACOLOGY; PNEUMONIA; THYROID GLAND; THYROTROPIN

Mesh：

Substances：

Year:  1964        PMID： 14228536     DOI： 10.1210/jcem-24-10-976

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

Review 1.  Endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1972-02-05

Review 2.  Aetiology of hyperthyroidism. II.

Authors:  R Hoffenberg
Journal:  Br Med J       Date:  1974-08-24

Review 3.  The long-acting thyroid stimulator.

Authors:  J P Kriss
Journal:  Calif Med       Date:  1968-09

Review 4.  Thyrotoxic muscle disease.

Authors:  I Ramsay
Journal:  Postgrad Med J       Date:  1968-05       Impact factor: 2.401

5.  LATS activity, exophthalmos and digital clubbing associated with myxoedema.

Authors:  P Beighton
Journal:  Postgrad Med J       Date:  1968-05       Impact factor: 2.401

6.  Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.

Authors:  C A Hardisty; A Fowles; D S Munro
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

7.  Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema.

Authors:  Changgui Lan; Liping Hu; Chengqi Liao; Yuhong Shi; Yi Wang; Shuanghua Cheng; Wei Huang
Journal:  J Clin Med Res       Date:  2020-11-03

8.  Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease.

Authors:  J R Wall; A Trewin; S L Fang; S H Ingbar; L E Braverman
Journal:  J Endocrinol Invest       Date:  1978-07       Impact factor: 4.256

Review 9.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.